0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]

50 MG/ML · Auto-Injector · injection

A form of adalimumab-aqvh →

0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry] — Tumor necrosis factor alpha (TNF-alpha) inhibitors. Strength, form, class, interactions & more.

0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]

Active ingredient

adalimumab-aqvh →

Classification

Tumor necrosis factor alpha (TNF-alpha) inhibitorsTumor Necrosis Factor Blocker

Drug interactions

Adalimumab-aqvh has several drug interactions that may increase the risk of serious infections or require monitoring of other medications.

  • majorabatacept — Increased risk of serious infection
  • majoranakinra — Increased risk of serious infection
  • majorlive vaccines — Avoid use
  • moderateCYP450 substrates with a narrow therapeutic index (e.g., warfarin, cyclosporine, theophylline) — Monitoring of effect or drug concentration is recommended

Real-world adverse events (FAERS)

Accidental Exposure to Product34Product Dose Omission Issue31Device Malfunction26No Adverse Event14Device Leakage9Product Quality Issue9Product Complaint6Drug Ineffective5

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →